FPFZX
Price
$8.84
Change
+$0.02 (+0.23%)
Updated
Jun 2 closing price
Net Assets
656.35M
FPNTX
Price
$10.29
Change
+$0.02 (+0.19%)
Updated
Jun 2 closing price
Net Assets
363.81M
Interact to see
Advertisement

FPFZX vs FPNTX

Header iconFPFZX vs FPNTX Comparison
Open Charts FPFZX vs FPNTXBanner chart's image
FPFZX vs FPNTX Comparison Chart in %
View a ticker or compare two or three
VS
FPFZX vs. FPNTX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FPFZX is a Hold and FPNTX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FPFZX has more cash in the bank: 656M vs. FPNTX (364M). FPFZX (3.51) and FPNTX (3.39) have matching dividends . FPFZX was incepted earlier than FPNTX: FPFZX (17 years) vs FPNTX (40 years). FPNTX (0.82) is less costly to investors than FPFZX (0.58). FPNTX is a more actively managed with annual turnover of: 28.00 vs. FPFZX (15.53). FPNTX has a lower initial minimum investment than FPFZX: FPNTX (2500) vs FPFZX (100000). FPNTX (8.58) and FPFZX (8.17) have marching annual gain over last year. FPNTX return over 5 years is better than : 3.00 vs. FPFZX (-0.66).
FPFZXFPNTXFPFZX / FPNTX
Total Expense Ratio0.580.8271%
Annual Report Gross Expense Ratio0.580.8271%
Fund Existence17 years40 years-
Gain YTD1.7131.72599%
Front LoadN/A4%-
Min. Initial Investment10000025004,000%
Min. Initial Investment IRAN/AN/A-
Net Assets656M364M180%
Annual Yield % from dividends3.513.39104%
Returns for 1 year8.178.5895%
Returns for 3 years11.6511.8998%
Returns for 5 years-0.663.00-22%
Returns for 10 years0.7614.175%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BLYAX39.640.22
+0.56%
American Beacon Man Lg Cp Growth A
LGPSX46.67N/A
N/A
ProFunds Large Cap Growth Svc
GCVAX27.27N/A
N/A
Goldman Sachs Large Cp Val Insghts A
IYBIX27.22N/A
N/A
Nomura Balanced Fund Class I
VPRAX28.28N/A
N/A
VY® T. Rowe Price Capital Apprec R6